Loading…
Grand Pharmaceutical Group (GP) announced it will acquire 100% of FastWave Medical Inc for up to $72 million, and invest up to $8 million to co-develop an intravascular shockwave calcification treatment system for arterial calcification. FastWave will become GP's wholly owned subsidiary and overseas R&D platform for precision interventional devices.
“the Group will acquire 100% equity of FastWave with up to total USD72 million by phases, and will invest up to total USD8 million for supporting and jointly developing an innovative medical device, intravascular shockwave calcification treatment system, for the treatment of moderate to severe arteri”grandpharm.com
Summarized from public sources; check the original articles before acting on it.